The U.S. outsources control of drug prices to Canada: weird! Richard Owens in the Financial Post
Having us do the dirty work of price controls on the U.S.'s behalf is bizarre and pathetic — and dangerous, writes Richard Owens...
Seizing pharma profits kills pharma investment: Richard Owens in the Financial Post
It’s time, well past time, for government to get out of the way of innovation and put the health and well-being of Canadians...
COVID's two new solitudes: Richard Owens in the Financial Post
By creating lockdowns and limiting economic and personal freedoms the public sector optimizes its own affairs at our expense, writes Richard Owens in...
GTIPA Virtual Summit 2020
On October 29, the Global Trade and Innovation Policy Alliance will be holding a summit bringing together alliance members and experts from around...
Drug prices can go too low: Richard C. Owens in the Financial Post
By determinedly reducing revenues Canada not only ensures the unavailability of existing medications, it sees to it that far fewer new ones will...
Our drug discovery system seems broken: Richard Owens in the Financial Post
Now more than ever, we should want drug companies to be able to charge high prices, writes Richard Owens in the Financial Post. Below...
The court backs creators, not universities: Richard Owens in the Financial Post
Universities have relied on 'fair dealing' provisions to photocopy mountains of material and distribute them to students, writes Richard Owens. By Richard Owens,...
Google should start playing nice with the news media: Richard Owens in The National Post
The internet is far better off with authoritative, factual sources of reference, such as are provided by professional, fact-checking newspapers. Google’s news service...
Econ 101: Drug price controls shrink supply: Richard Owens in the Financial Post
Increased drug revenues enable increased research and development expenditures, which in turn result in better health and longer lives, writes Richard Owens. By...
A better innovation policy: Protect ideas, don’t subsidize businesses: Richard Owens and Brett Byers in the Financial Post
Current innovation policies are a mess of disparate and expensive programs that dole out vast amounts of money wastefully and inefficiently, write Richard Owens...
